Britton KA, Fox CS. Ectopic fat depots and Cardiovascular disease. Circ. 2011;124:e837-41.
Lee M-J, Wu Y, Fried SK. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med. 2013;34:1–11.
Article CAS PubMed Google Scholar
Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a Presidential advisory from the American Heart Association. Circ. 2023;148:1606–35.
Powell-Wiley TM, Poirier P, Burke LE, Després J-P, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circ. 2021;143:e984-10.
Duell PB, Welty FK, Miller M, Chait A, Hammond G, Ahmad Z, Arteriosclerosis, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42:e168-85.
Article CAS PubMed Google Scholar
Subcutaneous and visceral. adipose tissue: structural and functional differences - Ibrahim – 2010 - Obesity Reviews - Wiley Online Library [Internet]. [cited 2024 Jun 10]. https://onlinelibrary.wiley.com/doi/https://doi.org/10.1111/j.1467-789X.2009.00623.x
Zhang X, Ha S, Lau HC-H, Yu J. Excess body weight: novel insights into its roles in obesity comorbidities. Sem Cancer Biol. 2023;92:16–27.
Kang PS, Neeland IJ. Body Fat distribution, diabetes Mellitus, and Cardiovascular Disease: an update. Curr Cardiol Rep. 2023;25:1555–64.
Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism - Clin Experimental. 2019;92:98–107.
Mukherjee AG, Renu K, Gopalakrishnan AV, Jayaraj R, Dey A, Vellingiri B, et al. Epicardial adipose tissue and cardiac lipotoxicity: a review. Life Sci. 2023;328:121913.
Article CAS PubMed Google Scholar
Rämö JT, Kany S, Hou CR, Friedman SF, Roselli C, Nauffal V, et al. Cardiovascular significance and Genetics of Epicardial and Pericardial Adiposity. JAMA Cardiol. 2024;9:418–27.
Karlsberg D, Steyer H, Fisher R, Crabtree T, Min JK, Earls JP, et al. Impact of visceral fat on coronary artery disease as defined by quantitative computed tomography angiography. Obes. 2023;31:2460–6.
Huang Y, Hu Y, Bao B. Relationship of body mass index and visceral fat area combination with arterial stiffness and cardiovascular risk in cardiovascular disease-free people: NHANES (2011–2018). Endocr Connect. 2023;12:e230291.
Article PubMed PubMed Central Google Scholar
Zheng D, Zhao C, Ma K, Ruan Z, Zhou H, Wu H, et al. Association between visceral adiposity index and risk of diabetes and prediabetes: results from the NHANES (1999–2018). PLoS ONE. 2024;19:e0299285.
Article CAS PubMed PubMed Central Google Scholar
The human type 2 diabetes-. specific visceral adipose tissue proteome and transcriptome in obesity | Scientific Reports. [cited 2024 Jun 19]. https://www.nature.com/articles/s41598-021-96995-0
Yamazaki H, Tauchi S, Machann J, Haueise T, Yamamoto Y, Dohke M, et al. Fat distribution patterns and future type 2 diabetes. Diabetes. 2022;71:1937–45.
Article CAS PubMed Google Scholar
Change in Visceral Adiposity Independently Predicts a Greater Risk of Developing Type 2 Diabetes Over. 10 Years in Japanese Americans | Diabetes Care | American Diabetes Association. [cited 2024 Jun 18]. https://diabetesjournals.org/care/article/36/2/289/38189/Change-in-Visceral-Adiposity-Independently
Gugliucci A. Chapter One - Biomarkers of dysfunctional visceral fat. In: Makowski GS, editor. Advances in Clinical Chemistry [Internet]. Elsevier; 2022 [cited 2024 Jun 18]. pp. 1–30. https://www.sciencedirect.com/science/article/pii/S0065242322000269
Yi W, Kim K, Im M, Ryang S, Kim EH, Kim M, et al. Association between visceral adipose tissue volume, measured using computed tomography, and cardio-metabolic risk factors. Sci Rep. 2022;12:387.
Article CAS PubMed PubMed Central Google Scholar
Jayedi A, Soltani S, Motlagh SZ, Emadi A, Shahinfar H, Moosavi H, et al. Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies. BMJ. 2022;376:e067516.
Article PubMed PubMed Central Google Scholar
Xu F, Earp JE, Riebe D, Delmonico MJ, Lofgren IE, Greene GW. The relationship between fat distribution and diabetes in US adults by race/ethnicity. Front Public Health. 2024;12:1373544.
Article PubMed PubMed Central Google Scholar
Isono S. Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway. Respirology. 2012;17:32–42.
Schwab RJ, Pasirstein M, Pierson R, Mackley A, Hachadoorian R, Arens R, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med. 2003;168:522–30.
Bazzocchi A, Diano D, Ponti F, Andreone A, Sassi C, Albisinni U, et al. Health and ageing: a cross-sectional study of body composition. Clin Nutr. 2013;32:569–78.
D’Angelo GF, de Mello AAF, Schorr F, Gebrim E, Fernandes M, Lima GF, et al. Muscle and visceral fat infiltration: a potential mechanism to explain the worsening of obstructive sleep apnea with age. Sleep Med. 2023;104:42–8.
Sekizuka H, Ono Y, Saitoh T, Ono Y. Visceral fat area by abdominal Bioelectrical impedance analysis as a risk of obstructive sleep apnea. Int Heart J. 2021;62:1091–5.
Deng H, Duan X, Huang J, Zheng M, Lao M, Weng F, et al. Association of adiposity with risk of obstructive sleep apnea: a population-based study. BMC Public Health. 2023;23:1835.
Article CAS PubMed PubMed Central Google Scholar
Chen G-P, Qi J-C, Wang B-Y, Lin X, Zhang X-B, Zhao J-M, et al. Applicability of visceral adiposity index in predicting metabolic syndrome in adults with obstructive sleep apnea: a cross-sectional study. BMC Pulm Med. 2016;16:37.
Article CAS PubMed PubMed Central Google Scholar
Zou J, Wang Y, Xu H, Xia Y, Qian Y, Zou J, et al. The use of visceral adiposity variables in the prediction of obstructive sleep apnea: evidence from a large cross-sectional study. Sleep Breath. 2020;24:1373–82.
Chen Q, Lin G, Huang J, Chen L, Li C, Feng D, et al. Effects of CPAP on visceral adipose tissue in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath. 2020;24:425–32.
Sinn DH, Kang D, Chang Y, Ryu S, Cho SJ, Paik SW, et al. Non-alcoholic fatty liver disease and the incidence of myocardial infarction: a cohort study. J Gastroenterol Hepatol. 2020;35:833–9.
Liu Y, Zhong G-C, Tan H-Y, Hao F-B, Hu J-J. Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis. Sci Rep [Internet]. 2019 [cited 2024 Jun 27];9:11124. https://www.nature.com/articles/s41598-019-47687-3
Ahmed HS, Wang N, Carr JJ, Ding J, Terry JG, VanWagner LB et al. The association between hepatic steatosis and incident cardiovascular disease, cancer, and all-cause mortality in a US multicohort study. Hepatology [Internet]. 2023 [cited 2024 Jun 26];77:2063–72. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11104447/
Khawaja T, Linge J, Leinhard OD, Al-Kindi SG, Rajagopalan S, Khera A, et al. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: results from the Dallas heart study. Prog Cardiovasc Dis. 2023;78:67–73.
Tejani S, McCoy C, Ayers CR, Powell-Wiley TM, Després J-P, Linge J, et al. Cardiometabolic Health Outcomes Associated with Discordant Visceral and Liver Fat Phenotypes: insights from the Dallas Heart Study and UK Biobank. Mayo Clin Proc [Internet]. 2022;97:225–37.
Linge J, Cariou B, Neeland IJ, Petersson M, Rodríguez Á, Dahlqvist Leinhard O. Skewness in body fat distribution pattern links to specific Cardiometabolic Disease Risk profiles. J Clin Endocrinol Metab. 2023;109:783–91.
Article PubMed Central Google Scholar
Peng H, Wang S, Wang M, Ye Y, Xue E, Chen X, et al. Nonalcoholic fatty liver disease and cardiovascular diseases: a mendelian randomization study. Metabolism. 2022;133:155220.
留言 (0)